These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6716032)

  • 1. Diminished lymphocytic cortisol metabolism-enhancing effect in endogenous thyrotoxicosis.
    Grinblat J; Klein A
    J Endocrinol; 1984 May; 101(2):149-53. PubMed ID: 6716032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cancer in patients by reduced lymphocytic cortisol metabolism-enhancing effect.
    Klein A; Kaufman H; Arie R; Hoogervorst-Spalter H; Semach E; Barkan A; Martfel J; Servadio C
    J Natl Cancer Inst; 1980 Nov; 65(5):857-61. PubMed ID: 6933254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor removal on the presence of lymphocytic cortisol metabolism-enhancing factor in plasma of cancer patients.
    Barkan A; Barkan E; Hoogervorst-Spalter H; Kaufman H; Klein A
    J Natl Cancer Inst; 1980 Jun; 64(6):1333-5. PubMed ID: 6929371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First isolation step of a plasma factor which enhances lymphocytic cortisol metabolism and which is reduced in cancer patients.
    Klein A; Stern M; Kaufmann H; Spalter E; Meyerson E; Hildesheim J
    Cancer Detect Prev; 1983; 6(1-2):107-10. PubMed ID: 6883372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and dysplasia of cervix in relation to reduced lymphocytic cortisol metabolism-enhancing effect.
    Klein A; Storch B; Beckerman A; Meyerson E; Colev S; Kaufmann H; Schachter A
    J Natl Cancer Inst; 1984 Mar; 72(3):605-7. PubMed ID: 6583443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
    Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N
    J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism.
    de Rave S; Bravenboer B; Loosveld OJ; Lockefeer JH; Goldschmidt HM
    Neth J Med; 1993 Feb; 42(1-2):48-52. PubMed ID: 8446224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.
    Erfurth EM; Hedner P
    J Endocrinol Invest; 1986 Oct; 9(5):407-12. PubMed ID: 3794185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokines in thyrotoxicosis.
    Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ACTH-like activity in plasma of patients with thyrotoxicosis.
    HILTON JG; BLACK WC; ATHOS W; McHUGH B; WESTERMANN CD
    J Clin Endocrinol Metab; 1962 Sep; 22():900-5. PubMed ID: 13907479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioimmunological estimation of triiodothyronine in plasma. Diagnostic value in an area with endemic goitre (author's transl)].
    Gehring D; Hoffman G; Thiele S; Ehret G
    Dtsch Med Wochenschr; 1975 May; 100(18):996-1001. PubMed ID: 1132323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Triiodothyronine thyrotoxicosis in nodular toxic goiter].
    Raskin AM; Alesov VZ; Lebedeva NA; Shlimovich PB
    Probl Endokrinol (Mosk); 1976; 22(3):30-3. PubMed ID: 59358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the assay of plasma triiodothyronine level for the diagnosis of hyperthyroidism and hypothyroidism].
    Wiersinga WM; Schellekens AP; Touber JL
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1349-58. PubMed ID: 581211
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro diagnosis of T3 thyrotoxicosis].
    Semenov VD
    Med Radiol (Mosk); 1983 Jun; 28(6):72-5. PubMed ID: 6688114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear binding of triiodothyronine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormones.
    Liewendahl K; Rosengård S; Lamberg BA
    Clin Chim Acta; 1978 Feb; 83(1-2):41-8. PubMed ID: 620467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of homologous plasma and fetal calf serum on human lymphocytic cortisol metabolism.
    Klein A; Kaufmann H; Arie R; Hoogervorst-Spalter HG; Joshua H
    Experientia; 1979 Jan; 35(1):114-5. PubMed ID: 421777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for 3,3',5'-triiodothyronine (reverse T3, R-T3) in unextracted human serum.
    Hüfner M; Grussendorf M
    Clin Chim Acta; 1976 Jun; 69(3):497-504. PubMed ID: 947601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine.
    Wiersinga WM; Touber JL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):293-8. PubMed ID: 885993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.